Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 06 - 22 save search
uniQure to Acquire Corlieve Therapeutics and Advance its Gene Therapy Program to Treat Temporal Lobe Epilepsy (TLE)
Published: 2021-06-22 (Crawled : 16:00) - globenewswire.com
QURE | $4.71 -0.63% -0.64% 430K
|
Health Technology
|
| O: 7.4%
H: 0.77%
C: -13.44%
RGNX | $17.49 -2.94% -3.03% 300K
|
Health Technology
|
| O: -0.6%
H: 0.47%
C: 0.21%
gene therapy therapy gene therapies
uniQure Announces Positive 52-Week Clinical Data from HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B and Provides Regulatory Update
Published: 2021-06-22 (Crawled : 16:00) - globenewswire.com
QURE | $4.71 -0.63% -0.64% 430K
|
Health Technology
|
| O: 7.4%
H: 0.77%
C: -13.44%
gene therapy positive therapy trial gene therapies
BioCardia to Present CardiAMP Cell Therapy Clinical Trial Data at European Society of Cardiology Heart Failure 2021Cell Therapy Platform Demonstrates High Dose CD34+ Cell Performance Characteristics in Patients with Ischemic Heart Failure
Published: 2021-06-22 (Crawled : 14:00) - biospace.com/
BCDA | $0.371 -0.7% -0.7% 100K
|
Health Technology
|
| O: 0.82%
H: 1.65%
C: -0.82%
heart europe cardiology therapy cardio trial cardiamp
NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -0.91%
H: 2.47%
C: 2.45%
stem cell therapy
Lineage’s OPC1 Cell Therapy for the Treatment of Spinal Cord Injury to Return to Clinical Testing
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
LCTX | $1.15 -8.0% 0.0% 760K
|
Health Technology
|
| O: 3.36%
H: 2.89%
C: -1.08%
treatment test therapy spinal cord
Continuous Renal Replacement Therapy (CRRT) Market worth $1.7 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2021-06-22 (Crawled : 11:00) - prnewswire.com
MDT | $79.25 -1.22% 0.0% 7.1M
|
Health Technology
|
| O: 0.64%
H: 0.62%
C: 0.31%
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
|
| O: 0.01%
H: 0.2%
C: -0.23%
renal therapy
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.